Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Drug Screening Market Outlook 

The drug screening market is likely to expand its roots at a strong CAGR of 16.1% during the forecast period. The market holds a share of US$ 7.3 billion in 2023 while it is anticipated to cross a value of US$ 32.4 billion by 2033.

The research report on the drug screening market explains that more and more people indulging in drug consumption of different types along with the increasing number of rehab centers. Furthermore, the new government policies limit the use of drugs and drug trafficking are pushing the sales of drug screening solutions. Drug addicts promoting violence and drug abuse are pushing authorities to control the dissemination of drugs. The misuse and black marketing of prescribed drugs are fueling the demand for drug screening solutions. Furthermore, the development of drug screening products with higher efficiency and effectiveness gains traction for drug screening solutions. The higher penetration of recreational drugs among young people is fueling the demand for advanced drug screening solutions. Higher limitations on occupational drugs in non-Islamic countries are fueling the demand for drug screening solutions.

The drug screening market outlook states that the upcoming drug testing technology that is smart, efficient, and fast is likely to transform the market. Furthermore, the workspace discipline and extended drug screening prospects are fueling the demand for drug screening products.

Attributes Details
Drug Screening Market CAGR (2023 to 2033) 16.1%
Drug Screening Market Size (2023) US$ 7.3 billion
Drug Screening Market Size (2033) US$ 32.4 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How is the Future Outlook (2023 to 2033)  for Drug Screening Market in Comparison to the Historical Pattern (2017 to 2022)

Short-term Growth: From 2017 to 2022, the global Drug Screening market registered a comparatively higher CAGR of 19.3%. The rise in regulatory approvals for the drug screening laboratory services market is ascribed to increased drug and alcohol usage and the implementation of rigorous legislation demanding alcohol and drug test. Bans on alcohol use in Islamic nations and limitations on an occupational drug tests in selected countries, on the other hand, may limit the market’s growth to some extent.

Mid-term Growth: Teenage illicit alcohol usage, rising road accidents owing to a drug overdose while driving, and prescription medication abuse are predicted to fuel market revenue growth. The growth between 2022 and 2028 is likely to be steady.

Long-term Growth: Covid-19 pandemic resulted in a worldwide restriction on the movement of people and led to the isolation of individuals in their own homes. This is the primary reason for the drop in demand for drug screening services as most of the workplaces were shut down, and healthcare resources were diverted to take care of covid-19 patients. However, apart from these factors limiting the growth, the market still thrives at a strong CAGR of 16.1% between 2023 and 2033.

What are the Drivers, Restraints, Opportunities, & Threats in the Drug Screening Market?

The development of improved screening technology and growing awareness of the benefits of alcohol or drug screening are creating business opportunities.

Drug misuse and alcohol usage are on the rise all around the world. According to the World Drug Report 2021, 275 million persons aged 15–64, or one out of every 18 people in that age group, took drugs at least once in the preceding year (range: 175 million to 374 million).

Drug use problems were expected to affect 36.3 million individuals worldwide, accounting for over 13% of the global population. Drug use killed about half a million individuals in the same year, and drug use disorders resulted in the loss of 18 million years of a healthy life, primarily owing to opioids.

Similar increases in alcohol intake have been seen, with the resultant rise in the prevalence of impaired driving. Development of drug screening products and services on the road, boosting the total market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Drivers are Limiting the Drug Screening Adoption?

Alcohol and drug tests in the workplace are considered a breach of employee privacy in certain nations, including Canada, Colombia, Argentina, Chile, and South Africa. In France, for example, pre-employment saliva drug testing is only done when doctors prescribe it.

Workplace alcohol and drug tests are illegal in Poland and the Czech Republic. In Canada, Eastern Canadian case laws allow alcohol and immunoassay drug tests only where occupational activities are fundamentally risky or when alcohol and drug testing is confined to a few specific circumstances.

What are the Opportunities for the Drug Screening Market?

Disruptions in the global supply chain, diminished demand, and client suspensions have all been experienced by companies in the drug screening sector. The test examines microscopic amounts of perspiration in the fingerprint to identify drugs and drug metabolites. This test might eventually replace urine, hair, and blood-based immunoassay drug test.

Although fingerprint-based swab drug test can help prevent the spread of COVID, it is non-invasive, portable, time-saving, and sanitary allows for social distancing, is user-friendly, and requires no unique sample collection or handling preparation.

This test is simple to administer whenever and wherever needed, making it ideal for workplace drug testing. To identify drugs and drug metabolites, a home drug test examines microscopic amounts of perspiration in the fingerprint. Workplaces, criminal justice, police enforcement, and drug recovery programs employ this test, which are offering opportunities to the market players.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of the Drug Screening Market

Drug Screening Market:

Attributes Drug Screening Market
CAGR (2023 to 2033) 16.1%
Market Value (2033) US$ 32.4 billion
Growth Factor The increased drug consumption along with the additional ruckus created is likely to fuel the demand for drug screening products.
Opportunity Services like consultation, onsite testing, offsite testing, and fit-to-work program are creating opportunities for the market.
Key Trends The government programs to limit drug use are shaping the growth trends for the market.

Drug Testing Market:

Attributes Drug Testing Market
CAGR (2023 to 2033) 4.7%
Market Value (2033) US$ 14.72 billion
Growth Factor The increased alcohol consumption among adolescents and the elderly is likely to fuel the demand for drug testing kits.
Opportunity The advent of corporate and workspace-based drug-controlling steps is likely to create opportunities for the drug-testing market
Key Trends Ban on alcohol and drug consumption during work hours at government organizations is shaping the trends for the market.

Alcohol Tester Market:

Attributes Alcohol Tester Market
CAGR (2023 to 2033) 6.9%
Market Value (2033) US$ 23.24 million
Growth Factor Higher cases of drunk-driving accidents and alcohol abuse are pushing organizations and governments to adopt alcohol testers.
Opportunity The advent of portable oral fluid testing along with stringent policies around alcohol consumption are creating opportunities for the alcohol tester market.
Key Trends Breathalyzer alcohol and drug testing equipment are creating growth trends in the market.

Drug Screening Market Country-wise Insights

Region Absolute Market Growth
Chinese US$ 8.8 billion
United Kingdom US$ 1.0 billion
China US$ 1.8 billion
Japan US$ 1.4 billion
South Korea US$ 837.2 million

Which Region leads the Market in terms of Market Share and CAGR?

The Higher Misuse of Prescribed Drugs along with the Stringent Government Policies fuels the Regional Growth

Region Attributes
United States Market CAGR (2023 to 2033) 15.8%
United States Market Absolute Doller Growth (US$ Mn/Bn) US$ 8.8 billion

According to the FMI market survey, the United States market thrives at a CAGR of 15.8% between 2023 and 2033 while it is expected to reach a value of US$ 11.5 billion by 2033. As there has been an increase in the consumption of illicit drugs by citizens of North American countries and the government increasingly investing in curbing drug abuse by establishing a drug screening laboratory services market, the region is expected to experience considerable growth in the years ahead. These factors make the United States the leading market in terms of market share and CAGR.

The growing burden of drunk and driving cases is also becoming a significant factor in law enforcement agencies growing demand for drug screening. Additionally, most of the primary critical players present in the North American drug screening market and adjoining areas have always favored the colossal market volume.

What makes China a Significance Drug Screening Market?

Increasing Cases of Drug Trafficking and Stringent Workspace Drug Norms flourishes the Sales of Drug Screening Solutions

Region Attributes
Chinese Market CAGR (2023 to 2033) 15.4%
Chinese Market Absolute Doller Growth (US$ Mn/Bn) US$ 1.8 billion

Chinese drug screening market future trends appear optimistic, with opportunities in the workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. These factors make it the leading market in terms of market share and CAGR.

Fingerprint-based drug testing is a new concept that has gained traction and is one of the emerging trends in the Chinese drug screening market as an impact of COVID-19 on the overall drug screening market. Due to the risk of spreading the infection, the coronavirus has made it challenging to conduct drug testing in hospitals, labs, and other facilities. However, the Chinese market is still expected to hold US$ 2.3 billion in 2033 while thriving at a CAGR of 15.4% by 2033.

Category-wise Insights

Segment Top Product and Service
Top Sub-segment Rapid Testing Devices
CAGR (2017 to 2022) 19.1%
CAGR (2023 to 2033) 15.8%
Segment Top End User
Top Sub-segment Drug Testing Laboratories
CAGR (2017 to 2022) 18.6%
CAGR (2023 to 2033) 15.4%

Faster, Efficient, and Effective Results make Rapid Testing Devices the Top Product and Service Segment

The product and services for the drug screening laboratory services market are categorized into drug screening products, analytical instruments, rapid testing devices, consumables, and drug screening services. Analytical Instruments are primarily breathalyzers, immunoassay analyzers, and chromatography instruments. Rapid testing devices have started gaining importance for drug monitoring programs and are predicted to overtake the global drug screening market in the coming years. This segment is further classified according to devices such as urine testing devices and oral fluid testing devices. The segment is expected to thrive at a CAGR of 15.8% by 2033.

Organizations and Government offices lacking Testing Equipment fuels the Traction for the Drug Testing Laboratories Segment

Based on end-user type, drug testing laboratories are the top segment that thrives at a CAGR of 15.4% between 2023 and 2033. This is due to the lack of drug testing and screening equipment in private and government organizations. Despite the development of innovative drug screening methods, drug testing laboratories and hospitals will remain the significant consumers of products in the drug screening market. The segment thrived at a higher CAGR of 18.6% between 2017 and 2022.

Competition Scenario

Market players rely on the use of innovative technologies to derive efficiency in the drug screening kits and devices and get a hold of a better position in the drug screening market. In addition to this, the focus has also been on inorganic growth to get the benefit of collaboration and mutual growth. The key players in the market include Labcorp, Quest Diagnostics, Abbott Laboratories, and Orasure Technologies.

Recent Market Developments

  • The Omega Hair 17-panel drug test can detect multiple psychoactive substances, particularly benzodiazepines. It was developed by Omega laboratories and was introduced in 2018.
  • Detection of any ingestion of Marijuana, CBD, and nicotine drugs by a vaping panel test was introduced by Psychemedics.
  • Two US companies named Infirmary Health and LabCorp have agreed to offer laboratory testing services in the countries of the Eastern Gulf Coast.

Major Contributors of the Drug Screening Market

  • Laboratory Corporation of America Holdings,
  • Hoffmann -La Roche Ltd
  • BioMerieux SA
  • Express Diagnostics Int’l, Inc.
  • Bio-Rad Laboratories Inc.
  • Biomedical Diagnostics
  • Danaher
  • Synergy Health plc.
  • Agilent Technologies
  • Shimadzu Medical Pvt. Ltd.
  • Alere Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Siemens Healthineers Private Limited
  • American Bio Medica Corporation
  • Sciteck, Inc.
  • ACM Global Laboratories.
  • CareHealth America
  • Clinical Reference Laboratory, Inc.

Key Segments

By Sample Type:

  • Urine samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By Product and Service:

  • Drug screening
  • Analytical Instruments
  • Rapid Testing Devices
  • Consumables
  • Drug Screening Service

By End User:

  • Drug Testing Laboratories
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges
  • Workplaces

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)

Frequently Asked Questions

Where is the Higher Demand for the Market?

North America is estimated to generate higher demand in 2023.

Which Regional Market is Estimated to Witness Higher Growth?

Asia Pacific is estimated to witness higher growth in 2023.

Which is the preferred Product Type for Making the Market?

The drug screening laboratory services market is likely to thrive at a CAGR of 15.8% by 2033.

How did the Market Developed in the Past?

From 2017 to 2022, the global market exhibited a 19.3% CAGR.

Which Key Asian Country Dominates in the Market?

China dominates the Asian market.

Table of Content

1. Executive Summary | Drug Screening Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Sample Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        5.3.1. Urine samples

        5.3.2. Breath Samples

        5.3.3. Oral Fluid Samples

        5.3.4. Hair Samples

        5.3.5. Other Samples

    5.4. Y-o-Y Growth Trend Analysis By Sample Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Service

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Product and Service, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product and Service, 2023 to 2033

        6.3.1. Drug Screening

        6.3.2. Analytical Instruments

        6.3.3. Rapid Testing Devices

        6.3.4. Consumables

        6.3.5. Service

    6.4. Y-o-Y Growth Trend Analysis By Product and Service, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Product and Service, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033

        7.3.1. Drug Testing Laboratories

        7.3.2. Criminal Justice and Law Enforcement Agencies

        7.3.3. Hospitals

        7.3.4. Drug Treatment Centers

        7.3.5. Individual Users

        7.3.6. Pain Management Centers

        7.3.7. Schools and Colleges

        7.3.8. Workplaces

    7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Sample Type

        9.2.3. By Product and Service

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Sample Type

        9.3.3. By Product and Service

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Sample Type

        10.2.3. By Product and Service

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Sample Type

        10.3.3. By Product and Service

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom (UK)

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Sample Type

        11.2.3. By Product and Service

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Sample Type

        11.3.3. By Product and Service

        11.3.4. By End User

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. Thailand

            12.2.1.5. Singapore

            12.2.1.6. Australia

            12.2.1.7. Rest of Asia Pacific

        12.2.2. By Sample Type

        12.2.3. By Product and Service

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Sample Type

        12.3.3. By Product and Service

        12.3.4. By End User

    12.4. Key Takeaways

13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of Middle East and Africa

        13.2.2. By Sample Type

        13.2.3. By Product and Service

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Sample Type

        13.3.3. By Product and Service

        13.3.4. By End User

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. USA

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By Sample Type

            14.1.2.2. By Product and Service

            14.1.2.3. By End User

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By Sample Type

            14.2.2.2. By Product and Service

            14.2.2.3. By End User

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By Sample Type

            14.3.2.2. By Product and Service

            14.3.2.3. By End User

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By Sample Type

            14.4.2.2. By Product and Service

            14.4.2.3. By End User

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By Sample Type

            14.5.2.2. By Product and Service

            14.5.2.3. By End User

    14.6. UK

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By Sample Type

            14.6.2.2. By Product and Service

            14.6.2.3. By End User

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By Sample Type

            14.7.2.2. By Product and Service

            14.7.2.3. By End User

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By Sample Type

            14.8.2.2. By Product and Service

            14.8.2.3. By End User

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By Sample Type

            14.9.2.2. By Product and Service

            14.9.2.3. By End User

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By Sample Type

            14.10.2.2. By Product and Service

            14.10.2.3. By End User

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By Sample Type

            14.11.2.2. By Product and Service

            14.11.2.3. By End User

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By Sample Type

            14.12.2.2. By Product and Service

            14.12.2.3. By End User

    14.13. Thailand

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By Sample Type

            14.13.2.2. By Product and Service

            14.13.2.3. By End User

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By Sample Type

            14.14.2.2. By Product and Service

            14.14.2.3. By End User

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By Sample Type

            14.15.2.2. By Product and Service

            14.15.2.3. By End User

    14.16. GCC Countries

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2022

            14.16.2.1. By Sample Type

            14.16.2.2. By Product and Service

            14.16.2.3. By End User

    14.17. South Africa

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2022

            14.17.2.1. By Sample Type

            14.17.2.2. By Product and Service

            14.17.2.3. By End User

    14.18. Israel

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2022

            14.18.2.1. By Sample Type

            14.18.2.2. By Product and Service

            14.18.2.3. By End User

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Sample Type

        15.3.3. By Product and Service

        15.3.4. By End User

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Laboratory Corporation of America Holdings

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Hoffmann -La Roche Ltd

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. BioMerieux SA

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Express Diagnostics Int’l, Inc.

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Bio-Rad Laboratories Inc.

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Biomedical Diagnostics

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Danaher

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Synergy Health plc.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Agilent Technologies

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Shimadzu Medical Pvt. Ltd.

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

        16.1.11. Alere Inc.

            16.1.11.1. Overview

            16.1.11.2. Product Portfolio

            16.1.11.3. Profitability by Market Segments

            16.1.11.4. Sales Footprint

            16.1.11.5. Strategy Overview

                16.1.11.5.1. Marketing Strategy

        16.1.12. Premier Biotech, Inc.

            16.1.12.1. Overview

            16.1.12.2. Product Portfolio

            16.1.12.3. Profitability by Market Segments

            16.1.12.4. Sales Footprint

            16.1.12.5. Strategy Overview

                16.1.12.5.1. Marketing Strategy

        16.1.13. Psychemedics Corporation

            16.1.13.1. Overview

            16.1.13.2. Product Portfolio

            16.1.13.3. Profitability by Market Segments

            16.1.13.4. Sales Footprint

            16.1.13.5. Strategy Overview

                16.1.13.5.1. Marketing Strategy

        16.1.14. Siemens Healthineers Private Limited

            16.1.14.1. Overview

            16.1.14.2. Product Portfolio

            16.1.14.3. Profitability by Market Segments

            16.1.14.4. Sales Footprint

            16.1.14.5. Strategy Overview

                16.1.14.5.1. Marketing Strategy

        16.1.15. American Bio Medica Corporation

            16.1.15.1. Overview

            16.1.15.2. Product Portfolio

            16.1.15.3. Profitability by Market Segments

            16.1.15.4. Sales Footprint

            16.1.15.5. Strategy Overview

                16.1.15.5.1. Marketing Strategy

        16.1.16. Sciteck, Inc.

            16.1.16.1. Overview

            16.1.16.2. Product Portfolio

            16.1.16.3. Profitability by Market Segments

            16.1.16.4. Sales Footprint

            16.1.16.5. Strategy Overview

                16.1.16.5.1. Marketing Strategy

        16.1.17. ACM Global Laboratories

            16.1.17.1. Overview

            16.1.17.2. Product Portfolio

            16.1.17.3. Profitability by Market Segments

            16.1.17.4. Sales Footprint

            16.1.17.5. Strategy Overview

                16.1.17.5.1. Marketing Strategy

        16.1.18. CareHealth America

            16.1.18.1. Overview

            16.1.18.2. Product Portfolio

            16.1.18.3. Profitability by Market Segments

            16.1.18.4. Sales Footprint

            16.1.18.5. Strategy Overview

                16.1.18.5.1. Marketing Strategy

        16.1.19. Clinical Reference Laboratory, Inc.

            16.1.19.1. Overview

            16.1.19.2. Product Portfolio

            16.1.19.3. Profitability by Market Segments

            16.1.19.4. Sales Footprint

            16.1.19.5. Strategy Overview

                16.1.19.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Recommendations

Healthcare

Drug Discovery Enzymes Market

Published : August 2023

Healthcare

Toxicology Drug Screening Market

Published : July 2023

Explore Healthcare Insights

View Reports